TOLONIUM CHLORIDE

US Previously Marketed

First approved in 1953

Details

Stereochemistry	ACHIRAL
Molecular Formula	C15H16N3S.Cl
Molecular Weight	305.826
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Cl-].CN(C)C1=CC2=C(C=C1)N=C3C=C(C)C(N)=CC3=[S+]2

InChI

InChIKey=HNONEKILPDHFOL-UHFFFAOYSA-M

InChI=1S/C15H16N3S.ClH/c1-9-6-13-15(8-11(9)16)19-14-7-10(18(2)3)4-5-12(14)17-13;/h4-8H,16H2,1-3H3;1H/q+1;/p-1

HIDE SMILES / InChI

Molecular Formula	C15H16N3S
Molecular Weight	270.373
Charge	1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22923899

Tolonium chloride (INN, also known as toluidine blue or TBO) is a phenothiazine that has been used as a hemostatic, a biological stain, and a dye for wool and silk. Tolonium chloride has also been used as a diagnostic aid for oral and gastric neoplasms and in the identification of the parathyroid gland in thyroid surgery. Toluidine blue has high affinity for acidic tissue components, thereby staining tissues rich in DNA and RNA. It has found wide applications both as vital staining in living tissues and as a special stain owing to its metachromatic property. Toluidine blue has been used in vivo to identify dysplasia and carcinoma of the oral cavity.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
DNA or RNA 3 Target ID: DNA or RNA Sources: https://www.ncbi.nlm.nih.gov/pubmed/22923899	Binding Agent 1064

Conditions

Condition	Modality	Highest Phase	Product
Menorrhagia 4 Sources: https://www.drugs.com/international/tolonium-chloride.html	Primary	Approved 8429	Blutene Approved Use Treatment and prevention of excessive menstrual flow.
Keratosis (leucoplakia) 3 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10903660	Diagnostic	Not Provided 504	Unknown Approved Use Unknown
Oral cancer 13 Sources: https://clinicaltrials.gov/ct2/show/NCT00655421	Diagnostic	Phase III 656	Unknown Approved Use Unknown
Chronic periodontitis 4 Sources: https://clinicaltrials.gov/ct2/show/NCT01330082	Diagnostic	Phase III 656	Unknown Approved Use Unknown

Doses

Dose	Population	Adverse events
2 mg/kg 1 times / day single, intravenous Studied dose Dose: 2 mg/kg, 1 times / day Route: intravenous Route: single Dose: 2 mg/kg, 1 times / day Sources: https://pubmed.ncbi.nlm.nih.gov/30349973/	unhealthy, 27 years n = 1 Health Status: unhealthy Condition: Lipedema Age Group: 27 years Sex: F Population Size: 1 Sources: https://pubmed.ncbi.nlm.nih.gov/30349973/	Other AEs: Edema... Other AEs: Edema Sources: https://pubmed.ncbi.nlm.nih.gov/30349973/
4 mg/kg 1 times / day single, intravenous (mean) Studied dose Dose: 4 mg/kg, 1 times / day Route: intravenous Route: single Dose: 4 mg/kg, 1 times / day Sources: https://pubmed.ncbi.nlm.nih.gov/4176446/	unhealthy, adult n = 27 Health Status: unhealthy Age Group: adult Population Size: 27 Sources: https://pubmed.ncbi.nlm.nih.gov/4176446/	Other AEs: Cardiac arrhythmia... Other AEs: Cardiac arrhythmia Sources: https://pubmed.ncbi.nlm.nih.gov/4176446/

AEs

AE	Significance	Dose	Population
Edema		2 mg/kg 1 times / day single, intravenous Studied dose Dose: 2 mg/kg, 1 times / day Route: intravenous Route: single Dose: 2 mg/kg, 1 times / day Sources: https://pubmed.ncbi.nlm.nih.gov/30349973/	unhealthy, 27 years n = 1 Health Status: unhealthy Condition: Lipedema Age Group: 27 years Sex: F Population Size: 1 Sources: https://pubmed.ncbi.nlm.nih.gov/30349973/
Cardiac arrhythmia		4 mg/kg 1 times / day single, intravenous (mean) Studied dose Dose: 4 mg/kg, 1 times / day Route: intravenous Route: single Dose: 4 mg/kg, 1 times / day Sources: https://pubmed.ncbi.nlm.nih.gov/4176446/	unhealthy, adult n = 27 Health Status: unhealthy Age Group: adult Population Size: 27 Sources: https://pubmed.ncbi.nlm.nih.gov/4176446/

Sourcing

Vendor/Aggregator	ID	URL
ChEBI	CHEBI:87648	https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:87648
ZINC	ZINC000004217587	http://zinc15.docking.org/substances/ZINC000004217587

PubMed

Title	Date	PubMed
ABC of oral health. Swellings and red, white, and pigmented lesions.	2000 Jul 22	10903660
Toluidine blue: A review of its chemistry and clinical utility.	2012 May	22923899

Patents

Sample Use Guides

In Vivo Use Guide

Examination of the oral cavity after the local application of Toluidine Blue dye (tolonium chloride)

Route of Administration: Other

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:34:12 UTC 2023` Edited by `admin` on `Fri Dec 15 15:34:12 UTC 2023`
Record UNII	15XUH0X66N
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TOLONIUM CHLORIDE

Official Name

English

SCHULTZ 1041

Brand Name

English

TOLUIDINE BLUE OO

Common Name

English

KLOT

Brand Name

English

NSC-36758

Code

English

C.I. BASIC BLUE 17

Common Name

English

MENODIN

Brand Name

English

TOLONIUM CHLORIDE [MART.]

Common Name

English

C.I. 52040

Common Name

English

BLUTENE CHLORIDE

Brand Name

English

PHENOTHIAZIN-5-IUM, 3-AMINO-7-(DIMETHYLAMINO)-2-METHYL-, CHLORIDE (1:1)

Systematic Name

English

GABILIN

Brand Name

English

BLUTENE

Brand Name

English

TOLAZUL

Brand Name

English

CI 52040

Common Name

English

3-AMINO-7-DIMETHYLAMINO-2-METHYLPHENAZATHIONIUM CHLORIDE

Common Name

English

Tolonium chloride [WHO-DD]

Common Name

English

BASIC BLUE 17

Common Name

English

PHENOTHIAZIN-5-IUM, 3-AMINO-7-(DIMETHYLAMINO)-2-METHYL-, CHLORIDE

Systematic Name

English

TOLUIDINE BLUE O

Common Name

English

NSC-11225

Code

English

tolonium chloride [INN]

Common Name

English

TOLONIUM CHLORIDE [MI]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C461